| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 157,408 shares worth roughly $644K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Borgeson Blake69 | Director | Sell10b5-1 | 170,000 | $3.46 | $588,200.00 | -2.6% | +7.1% | - | |
| Feb 19, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $3.46 | $138,400.00 | -4.2% | -20.4% | - | |
| Feb 18, 2026 | Taylor Ben R | Chief Financial Officer | Sell10b5-1 | 13,426 | $3.08 | $41,352.08 | -1.1% | -19.3% | - | |
| Feb 4, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $4.12 | $164,800.00 | -4.2% | -13.6% | - | |
| Feb 3, 2026 | Borgeson Blake69 | Director | Sell10b5-1 | 220,000 | $4.20 | $924,000.00 | -3.3% | -14.1% | - | |
| Jan 20, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $4.47 | $178,800.00 | -4.2% | -16.1% | - | |
| Jan 6, 2026 | Borgeson Blake69 | Director | Sell10b5-1 | 220,000 | $4.36 | $959,200.00 | -3.2% | -30.8% | - | |
| Jan 5, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $4.25 | $170,000.00 | -4.1% | -27.9% | - | |
| Dec 29, 2025 | Taylor Ben R | Chief Financial Officer | Sell10b5-1 | 21,383 | $4.18 | $89,380.94 | -2.7% | -31.2% | - | |
| Dec 22, 2025 | Khan Najat49 | Chief R&D Commercial Officer | Sell10b5-1 | 124,403 | $4.41 | $548,592.35 | -16.9% | -26.6% | - |